nCounter® copy number assays can be custom ordered for up to 800 user-defined targets.
Additionally, the nCounter v2 Cancer Copy Number Assay offers an off-the-shelf option for multiplexed quantification of 87 genes commonly amplified or deleted in cancer including PIK3CA, AKT, PTEN, BRCA, ERBB2, and MYC (see table below).
- Optimized for FFPE samples
- Copy number analysis of 87 genes commonly amplified or deleted in cancer
- Digital quantitation of highly amplified genes
- Specific detection of bi-allelic and multi-allelic number of copies
nCounter® v2 Cancer CN Assay Gene List
|Genomic regions analyzed in one reaction||87 genes commonly amplified or deleted in cancer (average 3 probes/region)|
|Recommended amount of starting material||300 ng total genomic DNA|
|Sample types supported
||Human genomic DNA from FFPE samples, fresh or frozen tissue, or cell lines|
|Number of copies detected||0-4, multiallelic|
|nCounter® Prep Station throughput||12 samples < 2.5 hours|
|nCounter® Digital Analyzer throughput||12 samples / 2.7 hours|
|Controls||54 invariant genomic regions and spike-in process controls|
|Product||Description||Catalog Number||Unit Size|
nCounter® v2 Cancer CN Assay
|Enables copy number quantification for 87 genes commonly amplified or deleted in cancer. Optimized for FFPE analysis. Master Kits sold separately.||XT-CSO-CAN2-12||12 reactions|
nCounter® Human Karyotype Panel
|Accurate monitoring of gross chromosomal abnormalities for all 24 human chromosomes. Master Kits sold separately.||XT-CSO-KAR15-12||12 reactions|
For Research Use Only. Not for use in diagnostic procedures.